LncRNA PCGEM1 promotes renal carcinoma progression by targeting miR-433-3p to regulate FGF2 expression
Authors:
- Xianguo CaiXCXianguo Cai
- Xianjun ZhangXZXianjun Zhang
- Licai MoLMLicai Mo
- Jialiang ZhuJZJialiang Zhu
- Hongyuan YuHYHongyuan Yu
- 31 March 2020
- journal article
- research article
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 27 (4) , 493-504
Abstract
Long non-coding RNAs (lncRNAs) are implicated in the development of carcinomas, containing renal carcinoma. The competing endogenous RNA (ceRNA) network is well-known in modulating the pathological and physiological processes of tumors. Still and allKeywords
This publication has 27 references indexed in Scilit:
- The landscape of long noncoding RNAs in the human transcriptomeNature Genetics, 2015
- Renal cell carcinoma: An update for the practicing urologistAsian Journal of Urology, 2015
- Reciprocal regulation of PCGEM1 and miR-145promote proliferation of LNCaP prostate cancer cellsJournal of Experimental & Clinical Cancer Research, 2014
- Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulationFrontiers in Genetics, 2014
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- Long non-coding RNAs: insights into functionsNature Reviews Genetics, 2009
- Non-protein coding RNA biomarkers and differential expression in cancers: a reviewJournal of Experimental & Clinical Cancer Research, 2008
- Sunitinib versus Interferon Alfa in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Renal-Cell CarcinomaNew England Journal of Medicine, 2005
- PCGEM1, a prostate-specific gene, is overexpressed in prostate cancerProceedings of the National Academy of Sciences, 2000